2023
DOI: 10.1097/wco.0000000000001183
|View full text |Cite
|
Sign up to set email alerts
|

Nerve ultrasound for the diagnosis and follow-up of peripheral neuropathies

Abstract: Purpose of reviewThe purpose if this review is to provide an overview of the available data on the use of nerve ultrasound for the diagnosis and follow-up of peripheral neuropathies. Recent findingsDuring the last decade, nerve ultrasound has been established as a complementary tool for the evaluation of morphological changes mostly for immune-mediated polyneuropathies. Through the development of ultrasound protocols for evaluation of disease-specific sites, nerve ultrasound has proven to be a practical, widel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
2
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 68 publications
1
2
1
Order By: Relevance
“…In the present study, the clinical examination revealing progressive distal symmetrical sensory symptoms with predominant hypoesthesia and NCS yielding a decrease mainly in SNAPs and less pronounced in CMAPs with preserved NCVs and F-wave latencies are compatible with a predominantly sensory, length-dependent axonal character of TIPN [27]. Slight CSA enlargements in distal nerves and at compression sites combined with a constant INV in HRUS can be interpreted as typical signs of an axonal, non-inflammatory neuropathy [23]. Paclitaxel hyperstabilizes the microtubules by inhibiting their depolymerization, thus leading to inhibition of mitosis and to alterations in the microtubule structure especially in distal nerve segments.…”
Section: Discussionsupporting
confidence: 61%
See 1 more Smart Citation
“…In the present study, the clinical examination revealing progressive distal symmetrical sensory symptoms with predominant hypoesthesia and NCS yielding a decrease mainly in SNAPs and less pronounced in CMAPs with preserved NCVs and F-wave latencies are compatible with a predominantly sensory, length-dependent axonal character of TIPN [27]. Slight CSA enlargements in distal nerves and at compression sites combined with a constant INV in HRUS can be interpreted as typical signs of an axonal, non-inflammatory neuropathy [23]. Paclitaxel hyperstabilizes the microtubules by inhibiting their depolymerization, thus leading to inhibition of mitosis and to alterations in the microtubule structure especially in distal nerve segments.…”
Section: Discussionsupporting
confidence: 61%
“…In our study, a mean sural nerve CSA of 3.3 mm 2 6 months after taxane treatment represents an increase compared to the results of a recent meta-analysis (Fisse et al [22,23], mean 2.4 mm 2 , 95% confidence interval 1.7-3.1 mm 2 ), to baseline and to the healthy control group. The healthy control group was introduced to make Lycan et al [4], taking into consideration that the sural nerve has a low interrater reliability in nerve ultrasound [26] and that multivariable analyses in small numbers can provide misleading signals despite significant results.…”
Section: Discussioncontrasting
confidence: 42%
“…540 The primary advantage of nerve ultrasound lies in its non-invasive and convenient nature, enabling the assessment of peripheral neuropathy through the use of a high-resolution ultrasound probe, as opposed to skin biopsy. 541 However, the positive findings of both skin biopsy and neuroultrasound cannot be directly linked to the diagnosis of pain. 542 The primary challenge in pain diagnosis is the absence of objective standards and effective assessment approaches.…”
Section: Approaches For Pain Assessment and Diagnosismentioning
confidence: 99%
“…High‐resolution ultrasound (HRUS) of peripheral nerves is a non‐invasive and reliable method [1] to visualize parts of the peripheral nervous system. It can be applied as a diagnostic tool in a broad spectrum of diseases of the peripheral nerves, such as entrapment syndromes, inflammatory and non‐inflammatory polyneuropathies [2, 3], and axonal degeneration, for example, in motor neuron disease [4], spinocerebellar ataxia [5] and Parkinson's disease [6]. In addition to these diagnostic applications, nerve HRUS cross‐sectional area (CSA) measurements offer a unique opportunity to analyze human peripheral nerve size in vivo over a wide age range.…”
Section: Introductionmentioning
confidence: 99%